NCR Tables - Distribution By Histopathology Findings

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
J01DD04	MEDAXONUM	G	Ceftriaxone (disodium) - 1g	1g	Injectable powder for solution+diluent	438,093 L.L
J01DD04	MEDAXONUM	G	Ceftriaxone (disodium) - 1g	1g	Injectable powder for solution	15,482,229 L.L
J01DD04	MEGION	G	Ceftriaxone (disodium 3.5 hydrate) - 1g	1g	Injectable powder for solution+diluent	552,259 L.L
J01DD04	MEGION-A	G	Ceftriaxone - 1g/3.5ml, Lidocaine (ampoule) -	1g/3.5ml	Injectable powder + solvent	599,719 L.L
J01DD04	MESPORIN-1000 IM	G	Ceftriaxone (sodium) - 1g	1,000mg	Injectable powder for solution+diluent	417,935 L.L
J01DD04	MESPORIN-1000 IV	G	Ceftriaxone (sodium) - 1g	1,000mg	Injectable powder for solution+diluent	417,935 L.L
J01DD04	ROCICARE	G	Ceftriaxone - 1g	1g	Injectable powder for solution	9,382,061 L.L
J01DD04	TRAVILAN IM	G	Ceftriaxone (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	438,093 L.L
J01DD04	TRIAXONE	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution	438,093 L.L
J01DD04	TRIAXONE	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution	4,542,188 L.L
J01DD04	VERACOL	G	Ceftriaxone (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	454,219 L.L
J01DD04	AXONE 500MG IM	G	Ceftriaxone (sodium) - 500mg	500mg	Injectable powder for solution+diluent	393,746 L.L
J01DD02	CEFTAZIDIME PANPHARMA	G	Ceftazidime (pentahydrate) - 1g	1g	Injectable powder for solution	3,300,477 L.L
J01DD02	FORTECARE	G	Ceftazidime - 1g	1g	Injectable powder for solution	10,011,695 L.L
J01DD02	NEGACEF	G	Ceftazidime (pentahydrate) - 1g	1g	Injectable dry powder for solution	4,421,242 L.L
J01DD01	CEFOTAX	G	Cefotaxime (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	217,702 L.L
J01DD01	CEFOTAXIME PANPHARMA	G	Cefotaxime (sodium) - 1g	1g	Injectable lyophilised powder for solution	6,127,922 L.L
J01DD01	CLAFOCARE	G	Cefotaxime (sodium) - 1g	1g	Injectable powder for solution	8,031,731 L.L
J01DD01	STOPAREN	G	Cefotaxime (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	213,671 L.L
J01DC10	CEFPROZ 250	G	Cefprozil - 250mg/5ml	250mg/5ml	Powder for suspension	712,237 L.L
J01DC10	CEFPROZ 250	G	Cefprozil - 250mg/5ml	250mg/5ml	Powder for suspension	1,343,843 L.L
J01DC04	CECLOR	B	Cefaclor (monohydrate) - 250mg/5ml	250mg/5ml	Granules for suspension	851,100 L.L
J01DC04	CLORACEF FORTE	G	Cefaclor (monohydrate) - 250mg/5ml	250mg/5ml	Powder for suspension	632,950 L.L
J01DC04	CECLOR MR	B	Cefaclor (monohydrate) - 500mg	500mg	Tablet, film coated, modified release	1,226,096 L.L
J01DC04	CECLOR MR	B	Cefaclor (monohydrate) - 750mg	750mg	Tablet, film coated, modified release	1,555,018 L.L
J01DC04	CECLOR	B	Cefaclor (monohydrate) - 125mg/5ml	125mg/5ml	Granules for suspension	487,623 L.L
J01DC02	MAXIL 750	G	Cefuroxime - 750mg	750mg	Injectable dry powder	159,917 L.L
J01DC02	ZILISTEN	G	Cefuroxime (sodium) - 750mg	750mg	Injectable dry powder	155,886 L.L
J01DC02	ZINNAT	B	Cefuroxime (axetil) - 500mg	500mg	Tablet, film coated	877,085 L.L
J01DC02	CEFORA	G	Cefuroxime (axetil) - 500mg	500mg	Tablet	703,918 L.L

جداول بيانية لسجل الوطني للسرطان - توزيع الحالات حسب خصائص الانسجة